Staurosporine exemplifies this by broadly inhibiting protein kinases, potentially impacting any kinase-related activity of LOC646960. In contrast, LY294002 and U0126 offer a more focused approach by obstructing PI3K and MEK pathways, respectively, thereby potentially altering LOC646960's role in cell survival, proliferation, and differentiation. Y-27632 disrupts Rho-associated kinase activity, which may affect LOC646960's influence on cell shape and motility, while SB431542 and PD98059 act on TGF-beta and the MAPK/ERK pathway to potentially alter cell cycle dynamics and apoptosis that LOC646960 may regulate.
Rapamycin's inhibition of mTOR signaling and SP600125's obstruction of JNK pathways offer insights into LOC646960's involvement in protein synthesis, cell growth, and stress responses. Calcium signaling, a nexus for numerous cellular processes, is targeted by BAPTA-AM and Thapsigargin, which may impinge on LOC646960's calcium-dependent activities. PD173074's ability to block FGFR signaling and ZM-447439's targeting of Aurora kinases provide a window into LOC646960's potential role in cell proliferation and division.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent protein kinase inhibitor that interferes with ATP binding, Staurosporine can inhibit a broad range of kinases that may be upstream or directly associate with LOC646960. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that blocks the PI3K/Akt signaling pathway, LY294002 can impede downstream effects that LOC646960 may have on cell survival and proliferation. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A ROCK inhibitor, Y-27632 can impair cytoskeletal rearrangements and may intersect with LOC646960's influence on cell shape and motility. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
This compound inhibits TGF-beta signaling, which could intersect with the pathways regulated by LOC646960, affecting cell cycle and apoptosis. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An inhibitor of MEK, PD98059 prevents the activation of MAPK/ERK pathway, potentially altering the signal transduction processes involving LOC646960. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
As an mTOR inhibitor, Rapamycin can disrupt the mTOR signaling pathway, which may be a part of the regulatory network of LOC646960, affecting protein synthesis and cell growth. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor, SP600125 can block the JNK signaling pathway which may be essential for the processes regulated by LOC646960, such as apoptosis and inflammation. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
A calcium chelator, BAPTA-AM can impede calcium-dependent signaling pathways that LOC646960 may utilize for its activity in cellular processes. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
An inhibitor of the sarco/endoplasmic reticulum Ca2+ ATPase (SERCA), Thapsigargin can elevate cytosolic calcium levels, thereby affecting calcium-dependent pathways associated with LOC646960. | ||||||
PD173074 | 219580-11-7 | sc-202610 sc-202610A sc-202610B | 1 mg 5 mg 50 mg | $47.00 $143.00 $680.00 | 16 | |
A selective FGFR inhibitor, PD173074 can block FGFR signaling which may influence the biological processes regulated by LOC646960, such as cell proliferation and differentiation. | ||||||